Location History:
- Antwerp, BE (2013)
- Antwerpen, BE (2016)
Company Filing History:
2 out of 1,746 
2 out of 223 
2 out of 932 
Years Active: 2013-2016
Title: The Innovations of Marc Cruts
Introduction
Marc Cruts is a notable inventor based in Antwerpen, Belgium. He has made significant contributions to the field of neurodegenerative disorders, particularly in the detection and treatment of dementia. With a total of 2 patents, his work is paving the way for advancements in medical research and treatment options.
Latest Patents
One of Marc Cruts' latest patents focuses on detecting and treating dementia. This document outlines methods and materials for identifying mutations linked to dementia. Specifically, it provides techniques for detecting one or more mutations within PGRN nucleic acid. Additionally, it includes methods for assessing the level of progranulin expression. The patent also discusses approaches for treating mammals with neurodegenerative disorders, such as dementia, by increasing PGRN polypeptide levels. Furthermore, it identifies agents that can be utilized to enhance these levels in mammals.
Career Highlights
Throughout his career, Marc Cruts has worked with esteemed organizations, including the Mayo Foundation for Medical Education and Research and Vib Vzw. His experience in these institutions has contributed to his expertise in the field of medical research and innovation.
Collaborations
Marc has collaborated with notable professionals in his field, including Michael L. Hutton and Matthew Charles Baker. These partnerships have further enriched his research and development efforts.
Conclusion
Marc Cruts is a distinguished inventor whose work in detecting and treating dementia is making a significant impact in the medical community. His innovative approaches and collaborations are essential in advancing the understanding and treatment of neurodegenerative disorders.